Capricor Therapeutics CAPR
NASDAQ CAPR
$5.88 -0.73 (-11.04%)
At close: Oct 21, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Receivables - Net (2023 - 2024)

Updated

Capricor Therapeutics' Receivables - Net was $20 million in Q4 2024, up 100.0% from $10 million a year earlier.

Analysis

Capricor Therapeutics (CAPR) Receivables - Net (2023 - 2024) Analysis & Trends

  • In earlier years, Receivables - Net was $10 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Capricor Therapeutics 339.74 Mn -593.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 20.00 Mn
Dec 31, 2023 10.00 Mn
API Access

Capricor Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CAPR&period=max&api_key=YOUR_API_KEY